Structure of Cetirizine
CAS No.: 83881-51-0
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Cetirizine, a second-generation antihistamine, is a major metabolite of hydroxyzine, and a racemic selective H1 receptor inverse agonist used in the treatment of allergies, hay fever, angioedema, and urticaria.
Synonyms: Cetirizine
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 83881-51-0 |
Formula : | C21H25ClN2O3 |
M.W : | 388.89 |
SMILES Code : | O=C(COCCN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(Cl)C=C3)O |
Synonyms : |
Cetirizine
|
MDL No. : | MFCD00800721 |
InChI Key : | ZKLPARSLTMPFCP-UHFFFAOYSA-N |
Pubchem ID : | 2678 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H315-H319-H335 |
Precautionary Statements: | P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501 |
In Vitro:
Concentration | Treated Time | Description | References |
rat peritoneal eosinophils | 10^-6 to 10^-4 M | 10 min | To evaluate the effect of cetirizine on PAF-induced eosinophil chemotaxis, results showed that cetirizine failed to inhibit PAF-induced eosinophil chemotaxis. | Br J Pharmacol. 1992 Jan;105(1):176-80. |
POAH neurons | 10 μM | Cetirizine completely blocked histamine-induced Ca2+ responses in POAH neurons | Br J Pharmacol. 2012 Jan;165(1):167-82. |
In Vivo:
Administration | Dosage | Frequency | Description | References |
Male Wistar rats | Pleurisy model | Intraperitoneal | 5 to 30 mg/kg | Single dose, 1 hour | To evaluate the inhibitory effect of cetirizine on PAF- or compound 48/80-induced pleural eosinophil accumulation. Results showed that cetirizine dose-dependently inhibited eosinophil accumulation induced by PAF and compound 48/80, with ED50 values of 19 mg/kg and 14 mg/kg, respectively. | Br J Pharmacol. 1992 Jan;105(1):176-80. |
Male Wistar rats | Pleurisy model | Intrathoracic injection | 5 and 15 μg/cavity | 5 minutes (i.t.) before pretreatment | To evaluate the inhibitory effect of cetirizine on PAF- or compound 48/80-induced pleural eosinophil accumulation. Results showed that intrathoracic administration of low doses of cetirizine (5 and 15 μg/cavity) also significantly inhibited eosinophil accumulation. | Br J Pharmacol. 1992 Jan;105(1):176-80. |
Guinea pigs | Non-immunized guinea pigs receiving platelets from immunized animals | Intravenous injection | 10-30 mg/kg | Administered 1 hour before antigen challenge | Cetirizine dose-dependently inhibited platelet-dependent leucopenia, with the highest dose achieving complete inhibition. | Br J Pharmacol. 1991 Jun;103(2):1520-4 |
Rats | Sprague-Dawley rats | Intracerebroventricular infusion | 10μM/100μL | 10 hours | Cetirizine significantly increased non-REM sleep, abolished REM sleep, and decreased wakefulness for more than 10 h | Br J Pharmacol. 2012 Jan;165(1):167-82. |
Balb/C mice | Ovalbumin-induced peritonitis model | Subcutaneous injection | 15-30 mg/kg | 1 hour before and 6 hours after | Cetirizine significantly reduced ovalbumin-induced eosinophil accumulation, whereas terfenadine was ineffective, suggesting that the effect of cetirizine was not related to the inhibition of the H1 receptor effects of histamine. | Br J Pharmacol. 1993 Oct;110(2):917-24 |
Guinea-pigs | Ovalbumin-sensitized guinea-pig paw oedema model | Subcutaneous injection | 20 mg/kg | Single dose, measured after 30 minutes | To evaluate the effect of cetirizine on ovalbumin-induced paw oedema, results showed cetirizine did not inhibit the oedema | Br J Pharmacol. 1994 May;112(1):111-6 |
Guinea pigs | OA-sensitized guinea pigs | Intraperitoneal injection | 10 mg/kg | Single dose, 1 hour before | To evaluate the effect of cetirizine on OA-induced bronchoconstriction. Cetirizine significantly inhibited OA-induced bronchoconstriction (70% inhibition). | Br J Pharmacol. 2012 Jul;166(6):1822-32 |
Rats | Anesthetized rat dural blood flow model | Intravenous injection | 50 mg/kg | Single dose | To investigate the effect of cetirizine on histamine-induced increases in dural blood flow. Results showed that i.v. cetirizine significantly reduced the flow increases induced by i.v. histamine administration. | Br J Pharmacol. 2002 Nov;137(6):874-80 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT02372604 | Chronic Spontaneous Urticaria | Phase 3 | Completed | - | - |
NCT01567501 | Fed | Phase 1 | Completed | - | India ... More >> Accutest Research Lab (I) Pvt. Ltd. Ahmedabad, Gujarat, India, 380054 Less << |
NCT03555890 | Rhinitis | Phase 1 | Completed | - | Japan ... More >> GSK Investigational Site Fukuoka, Japan, 812-0025 Less << |
NCT02394119 | Nephrotic Syndrome | Phase 2 | Recruiting | May 2019 | Italy ... More >> IRCCS Istituto Giannina Gaslini Recruiting Genoa, Italy/GE, Italy, 16147 Contact: Gian Marco Ghiggeri, MD 0039 010 5636 2419 gmarcoghiggeri@ospedale-gaslini.ge.it Principal Investigator: Gian Marco Ghiggeri, MD Sub-Investigator: Alice Bonanni, MD Less << |
NCT02394106 | Nephrotic Syndrome | Phase 2 | Recruiting | March 2018 | Italy ... More >> IRCCS Istituto Giannina Gaslini Recruiting Genoa, Italy/GE, Italy, 16147 Contact: Gian Marco Ghiggeri, MD 0039 010 5636 2419 gmarcoghiggeri@ospedale-gaslini.ge.it Principal Investigator: Gian Marco Ghiggeri, MD Sub-Investigator: Alice Bonanni, MD Less << |
NCT02771249 | Healthy Volunteers | Phase 1 | Recruiting | December 31, 2019 | United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov Less << |
NCT00557284 | - | Completed | - | - | |
NCT00001910 | - | Completed | - | United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less << | |
NCT03590912 | Otitis Media With Effusion | Phase 4 | Not yet recruiting | September 2019 | Nepal ... More >> Lumbini Medical College Tansen, Palpa, Nepal, 32500 Less << |
NCT00557284 | Atopic Dermatitis | Phase 4 | Completed | - | United States, Colorado ... More >> 1st Allergy & Clinical Research Centers Centennial, Colorado, United States, 80112 1st Allergy & Clinical Research Centers Thornton, Colorado, United States, 80229 Less << |
NCT02873364 | Urticaria | Phase 3 | Unknown | January 2017 | Iran, Islamic Republic of ... More >> Shiraz University of Medical Sciences Recruiting Shiraz, Fars, Iran, Islamic Republic of Contact: Keramatallah Jahanshahi, MD +989177416523 kjahanshahi91@gmail.com Less << |
NCT03523221 | Mild -Moderate Anaphylaxis - S... More >>ymptoms That Affect the Skin With Cardiovascular, Respiratory or Gastrointestinal Involvement, But no Signs of Hypotension ,Laryng Less << | Phase 1 | Recruiting | August 2020 | Qatar ... More >> Hamad Medical Corporation Recruiting Doha, Qatar, 3050 Contact: Rafah Sayyed, MD +97455747045 ralsayyed@hamad.qa Less << |
NCT03296358 | Urticaria All... More >>ergy Less << | Not Applicable | Recruiting | October 31, 2019 | Thailand ... More >> Chulalongkorn Hospital Recruiting Pathum Wan, Bangkok, Thailand, 10600 Contact: Pakhawadee Palungwachira, Bachelor 66897704758 zaphyr_s@yahoo.com Principal Investigator: Pakhawadee Palungwachira, Bachelor Sub-Investigator: Katsara Vilaisri, Bachelor Sub-Investigator: Klongwong Musikatavorn, Bachelor Less << |
NCT01451996 | - | Completed | - | - | |
NCT01451996 | Healthy | Phase 4 | Completed | - | United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less << |
NCT02613910 | Pemphigus | Phase 3 | Terminated(Novartis has acquir... More >>ed the rights to ofatumumab and terminated the OPV116910 and OPV117059 studies. This decision is not linked to any safety consideration.) Less << | - | United States, California ... More >> GSK Investigational Site Los Angeles, California, United States, 90045 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48103 Less << |
NCT02646904 | Allergic Rhinitis | Phase 4 | Completed | - | Italy ... More >> Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council Palermo, Sicily, Italy, 90146 Institute of Biomedicine and Molecular Immunology, IBIM Palermo, Italy, 90146 Less << |
NCT02613910 | - | Terminated(Novartis has acquir... More >>ed the rights to ofatumumab and terminated the OPV116910 and OPV117059 studies. This decision is not linked to any safety consideration.) Less << | - | - | |
NCT01985789 | Asthma | Phase 4 | Completed | - | Canada, Saskatchewan ... More >> University of Saskatchewan Saskatoon, Saskatchewan, Canada, S7N 0W8 Less << |
NCT02583594 | Progressive Multiple Sclerosis | Phase 1 | Active, not recruiting | April 2021 | Spain ... More >> Investigational Site Number 724001 Barcelona, Spain, 08035 Less << |
NCT01902836 | Childhood Atopic Dermatitis | Phase 2 | Completed | - | Mexico ... More >> Hospital Infantil de México, Fedérico Gómez México, DF, Mexico, 06720 Less << |
NCT01981499 | Migraine | Phase 1 | Terminated(The trial was prema... More >>turely terminated on 01April2014 due to safety concerns.) Less << | - | United States, Minnesota ... More >> Pfizer Investigational Site St. Paul, Minnesota, United States, 55114 Less << |
NCT02024152 | Acute Urticaria | Phase 1 | Completed | - | Canada, Quebec ... More >> Algorithme Pharma Montreal, Quebec, Canada Less << |
NCT01940393 | Urticaria | Phase 4 | Completed | - | Colombia ... More >> Medellin Medellin, Antioquia, Colombia Less << |
NCT01241214 | Seasonal Allergic Rhinitis | Phase 2 | Completed | - | United States, Texas ... More >> Clinical Investigative Site 7905 Austin, Texas, United States, 78731 Clinical Investigative Site 7907 Kerrville, Texas, United States, 78028 Clinical Investigative Site 7903 New Braunfels, Texas, United States, 78130 Clinical Investigative Site 7901 San Antonio, Texas, United States, 78229 Clinical Investigative Site 7902 San Antonio, Texas, United States, 78229 Clinical Investigative Site 7904 San Antonio, Texas, United States, 78229 Clinical Investigative Site 7906 San Antonio, Texas, United States, 78229 Less << |
NCT02535416 | Healthy | Phase 1 | Completed | - | Australia, Queensland ... More >> QPharm, Pty Limited, Royal Brisbane Hospital Herston, Queensland, Australia, 4029 Less << |
NCT02535416 | - | Completed | - | - | |
NCT00561717 | Seasonal Allergic Rhinitis | Phase 4 | Completed | - | Canada, Ontario ... More >> Kingston, Ontario, Canada, K7L 2V7 Less << |
NCT00517946 | - | Completed | - | United Kingdom ... More >> GSK Investigational Site London, United Kingdom, W1G 8HU Less << | |
NCT01134328 | - | Completed | - | - | |
NCT01008592 | - | Terminated(Mediators of intere... More >>st were not consistently detectable with the analytical methods employed.) Less << | - | United States, North Carolina ... More >> Wake Forest University Health Sciences, Department of Dermatology Winston-Salem, North Carolina, United States, 27157 Less << | |
NCT01318681 | Seasonal Allergic Rhinitis ... More >> Driving Ability Cognition Less << | Not Applicable | Completed | - | Netherlands ... More >> Maastricht University Maastricht, Limburg, Netherlands, 62ooMD Less << |
NCT00533637 | Allergic Rhinitis | Phase 2 | Completed | - | Sweden ... More >> Department of Otorhinolaryngology, Lund University Hospital Lund, Sweden, SE-221 85 Less << |
NCT01484119 | Seasonal Allergic Rhinitis | Phase 3 | Completed | - | United States, Texas ... More >> Clinical Investigative Site 7905 Austin, Texas, United States, 78731 Clinical Investigative Site 7907 Kerrville, Texas, United States, 78028 Clinical Investigative Site 7903 New Braunfels, Texas, United States, 78130 Clinical Investigative Site 7901 San Antonio, Texas, United States, 78229 Clinical Investigative Site 7902 San Antonio, Texas, United States, 78229 Clinical Investigative Site 7904 San Antonio, Texas, United States, 78229 Clinical Investigative Site 7906 San Antonio, Texas, United States, 78229 Less << |
NCT02935699 | Acute Urticaria | Phase 3 | Recruiting | April 2018 | United States, Texas ... More >> City Doc Urgent Care center Recruiting Dallas, Texas, United States, 75209 Contact: Brook Jackson Canada, Ontario Ottawa Hospital Recruiting Ottawa, Ontario, Canada, K1Y 4E9 Contact: Cathy Clement Less << |
NCT01068223 | Histamine Induced Itch | Phase 1 | Completed | - | United Kingdom ... More >> Harrow, United Kingdom Less << |
NCT00610584 | Seasonal Allergic Rhinitis | Not Applicable | Completed | - | Germany ... More >> Charité - Institute for Social Medicine Berlin, Germany, 10098 Less << |
NCT00291642 | Rhinitis Alle... More >>rgic Seasonal Less << | Phase 2 | Completed | - | Canada, Ontario ... More >> Kingston, Ontario, Canada Less << |
NCT00974571 | - | Completed | - | - | |
NCT01134328 | Allergic Conjunctivitis | Phase 2 | Completed | - | United States, Massachusetts ... More >> Ora, Inc Andover, Massachusetts, United States, 01810 Less << |
NCT01495338 | Normal Ocular Health | Phase 1 | Completed | - | United States, Massachusetts ... More >> Andover Eye Associates Andover, Massachusetts, United States, 01810 Less << |
NCT03167216 | Chronic Prostatitis With Chron... More >>ic Pelvic Pain Syndrome Less << | Early Phase 1 | Recruiting | June 30, 2021 | United States, Illinois ... More >> Northwestern Medical Faculty Foundation Recruiting Chicago, Illinois, United States, 60611 Principal Investigator: Praveen Thumbikat, PhD Less << |
NCT01825655 | Pruritus | Phase 4 | Terminated(Unable to recruit p... More >>atients) Less << | - | United States, Virginia ... More >> Children's Hospital of Richmond at VCU Richmond, Virginia, United States, 23298 Less << |
NCT00974571 | Perennial Allergic Rhinitis | Phase 3 | Completed | - | - |
NCT01825655 | - | Terminated(Unable to recruit p... More >>atients) Less << | - | - | |
NCT00474890 | Atopy Rhiniti... More >>s Less << | Not Applicable | Completed | - | Germany ... More >> Fraunhofer Institute for Toxicology and Experimental Medicine Hannover, Germany, 30625 Less << |
NCT02451579 | Actinic Keratoses | Not Applicable | Completed | - | United States, California ... More >> Cosmetic Laser Dermatology San Diego, California, United States, 92121 Less << |
NCT00851344 | Rhinitis, Allergic, Seasonal | Phase 2 | Completed | - | Germany ... More >> GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 Less << |
NCT02447393 | Dermatitis | Phase 1 | Completed | - | Japan ... More >> GSK Investigational Site Kagoshima, Japan, 890-0081 Less << |
NCT00972504 | Rhinitis, Allergic, Seasonal | Phase 2 | Completed | - | Germany ... More >> GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 Less << |
NCT00291642 | - | Completed | - | - | |
NCT00972504 | - | Completed | - | - | |
NCT00257595 | Rhinitis, Allergic, Perennial | Phase 3 | Completed | - | - |
NCT00420082 | Seasonal Allergic Rhinitis | Phase 2 | Completed | - | Austria ... More >> Allergy Center Vienna West Vienna, Austria, A-1150 Less << |
NCT02543346 | Allergic Rhinitis | Phase 4 | Completed | - | United States, Texas ... More >> Biogenics Research Chamber San Antonio, Texas, United States, 78229 Canada, Ontario Kingston General Hospital Kingston, Ontario, Canada, K7L 2V7 Less << |
NCT00240032 | Multiple Sclerosis | Phase 4 | Completed | - | - |
NCT01103050 | Allergic Rhinitis | Phase 2 | Completed | - | Canada ... More >> Novartis Investigative Site Ontario, Canada Less << |
NCT00544388 | Rhinitis, Allergic, Seasonal | Phase 3 | Completed | - | - |
NCT02173249 | Healthy | Phase 1 | Completed | - | United States, Massachusetts ... More >> Andover Eye Associates Andover, Massachusetts, United States, 01810 Less << |
NCT00253058 | Rhinitis, Allergic, Perennial | Phase 3 | Completed | - | - |
NCT03192488 | Exercise Intolerance at Altitu... More >>de Less << | Phase 4 | Recruiting | May 31, 2018 | United States, Indiana ... More >> Indiana University Recruiting Bloomington, Indiana, United States, 47401 Contact: Robert Chapman, PhD 812-856-2452 rfchapma@indiana.edu Less << |
NCT00257569 | Dermatitis, Atopic | Phase 3 | Completed | - | - |
NCT01651871 | Seasonal Allergic Rhinitis | Phase 2 | Completed | - | - |
NCT00334698 | Seasonal Allergic Rhinitis | Not Applicable | Completed | - | Germany ... More >> Fraunhofer-Institute of Toxicology and Experimental Medicine Hannover, Germany, 30623 Less << |
NCT01881113 | Allergic Conjunctivitis | Phase 3 | Completed | - | United States, Massachusetts ... More >> Ora, Inc. Andover, Massachusetts, United States, 01810 Less << |
NCT01322282 | Allergy | Phase 1 | Completed | - | Canada, Quebec ... More >> Algorithme Pharma Inc. Mount-Royal, Quebec, Canada, H3P 3P1 Less << |
NCT01748344 | Seasonal Allergic Rhinitis | Phase 2 | Completed | - | Austria ... More >> Vienna Clinical Site Vienna, Austria Less << |
NCT01881113 | - | Completed | - | - | |
NCT01127620 | Perennial Allergic Rhinitis | Phase 3 | Completed | - | - |
NCT01551056 | Allergic Conjunctivitis | Phase 3 | Completed | - | United States, Massachusetts ... More >> Ora, Inc. Andover, Massachusetts, United States, 01810 Less << |
NCT01685242 | - | Completed | - | - | |
NCT01551056 | - | Completed | - | - | |
NCT01685242 | Allergic Conjunctivitis | Phase 3 | Completed | - | United States, Massachusetts ... More >> Andover Eye Associates Andover, Massachusetts, United States, 01810 Less << |
NCT00490204 | Rhinitis, Allergic, Perennial | PHASE3 | COMPLETED | 2007-10-03 | GSK Investigational Site, Chib... More >>a, 277-0882, Japan|GSK Investigational Site, Fukuoka, 807-0856, Japan|GSK Investigational Site, Fukuoka, 811-1201, Japan|GSK Investigational Site, Fukuoka, 819-0002, Japan|GSK Investigational Site, Hokkaido, 001-0923, Japan|GSK Investigational Site, Hokkaido, 007-0840, Japan|GSK Investigational Site, Hokkaido, 053-0833, Japan|GSK Investigational Site, Hokkaido, 061-1133, Japan|GSK Investigational Site, Hokkaido, 061-1448, Japan|GSK Investigational Site, Hokkaido, 062-0034, Japan|GSK Investigational Site, Kanagawa, 212-0027, Japan|GSK Investigational Site, Kanagawa, 213-0011, Japan|GSK Investigational Site, Kanagawa, 216-0002, Japan|GSK Investigational Site, Kanagawa, 222-0011, Japan|GSK Investigational Site, Kanagawa, 224-0003, Japan|GSK Investigational Site, Kanagawa, 232-0056, Japan|GSK Investigational Site, Kumamoto, 862-0952, Japan|GSK Investigational Site, Kumamoto, 862-0962, Japan|GSK Investigational Site, Oita, 870-0021, Japan|GSK Investigational Site, Saitama, 333-0861, Japan|GSK Investigational Site, Saitama, 336-0022, Japan|GSK Investigational Site, Saitama, 350-1205, Japan|GSK Investigational Site, Saitama, 355-0062, Japan|GSK Investigational Site, Shizuoka, 420-0803, Japan|GSK Investigational Site, Shizuoka, 422-8066, Japan|GSK Investigational Site, Shizuoka, 436-0058, Japan|GSK Investigational Site, Tokyo, 157-0067, Japan|GSK Investigational Site, Tokyo, 170-0005, Japan Less << |
NCT03047278 | Neuropathic Pain ... More >> Type 2 Diabetes Mellitus Diabetic Neuropathy, Painful Less << | Phase 4 | Enrolling by invitation | July 1, 2019 | - |
NCT00257582 | Pruritus | Phase 3 | Completed | - | - |
NCT00751218 | Urticaria | Phase 4 | Completed | - | - |
NCT00637455 | Seasonal Allergic Rhinitis | Phase 4 | Completed | - | United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less << |
NCT00504933 | Seasonal Allergic Rhinitis | Phase 3 | Completed | - | - |
NCT02756624 | Healthy Subjects | Phase 3 | Completed | - | United States, Massachusetts ... More >> Ora Clinical Site Network Andover, Massachusetts, United States, 01810 Less << |
NCT02756624 | - | Completed | - | - | |
NCT00881127 | Allergies | Phase 1 | Completed | - | - |
NCT00150761 | Anti-allergic Agents | Phase 4 | Completed | - | - |
NCT01622283 | Rhinitis, Allergic, Perennial ... More >>and Seasonal Less << | Phase 1 | Completed | - | Japan ... More >> GSK Investigational Site Kagoshima, Japan, 890-0081 Less << |
NCT00488176 | Seasonal Allergic Rhinitis | Phase 4 | Unknown | December 2013 | Poland ... More >> Department of Pediatrics and Allergy, Medical University of Lodz Lodz, Poland Recruiting Lodz, Poland, 93-513 Contact: Violetta Ścibiorek, MD 00 48 42 689 59 72 alergol@kopernik.lodz.pl Principal Investigator: Iwona Stelmach, MD, PhD, Prof Less << |
NCT00751166 | Urticaria | Phase 4 | Terminated(Study could not be ... More >>re-supplied with study medication in a timely manner.) Less << | - | - |
NCT01332188 | Allergic Conjunctivitis | Phase 2 Phase 3 | Completed | - | United States, Massachusetts ... More >> Ora, Inc. Andover, Massachusetts, United States, 01810 Less << |
NCT00375713 | - | Completed | - | - | |
NCT00881634 | Allergies | Phase 1 | Completed | - | - |
NCT01332188 | - | Completed | - | - | |
NCT00779116 | Allergies | Phase 4 | Completed | - | - |
NCT00649857 | Healthy | Phase 1 | Completed | - | United States, Texas ... More >> Novum Pharmaceutical Research Services Houston, Texas, United States, 77042 Less << |
NCT00779116 | - | Completed | - | - | |
NCT00780403 | Allergies | Phase 4 | Completed | - | - |
NCT00826943 | Allergic Rhinitis | Phase 4 | Completed | - | United States, Tennessee ... More >> Vanderbilt University Asthma, Sinus, and Allergy Clinic Nashville, Tennessee, United States, 37203 Less << |
NCT00780403 | - | Completed | - | - | |
NCT00794495 | Seasonal Allergic Rhinitis ... More >> Perennial Allergic Rhinitis Less << | Phase 4 | Completed | - | - |
NCT00375713 | Dermatitis Ec... More >>zema Less << | Phase 3 | Completed | - | Korea, Republic of ... More >> Gyeunggi-do, Korea, Republic of Kyeonggi-Do, Korea, Republic of Seoul, Korea, Republic of Less << |
NCT00650065 | Healthy | Phase 1 | Completed | - | United States, Texas ... More >> Novum Pharmaceutical Research Services Houston, Texas, United States, 77042 Less << |
NCT00794846 | Seasonal Allergic Rhinitis ... More >> Perennial Allergic Rhinitis Less << | Phase 4 | Completed | - | - |
NCT00639587 | Rhinitis, Allergic, Perennial | Phase 3 | Completed | - | - |
NCT02132169 | Atopic Disease (Including Alle... More >>rgic Conjunctivitis) Less << | Phase 3 | Completed | - | United States, Massachusetts ... More >> Ora, Inc. Andover, Massachusetts, United States, 01810 Less << |
NCT00826943 | - | Completed | - | - | |
NCT00794599 | Seasonal Allergic Rhinitis ... More >> Perennial Allergic Rhinitis Less << | Phase 4 | Completed | - | - |
NCT01916226 | Rhinitis, Allergic, Perennial ... More >>and Seasonal Less << | Phase 4 | Completed | - | - |
NCT00794378 | Allergic Rhinitis | Phase 3 | Completed | - | - |
NCT00794794 | Allergic Rhinitis | Phase 3 | Completed | - | - |
NCT00776022 | Healthy | Not Applicable | Completed | - | United States, Maryland ... More >> Bioanalytical Systems, Inc Baltimore, Maryland, United States, 21201 Less << |
NCT00776139 | Healthy | Not Applicable | Completed | - | United States, Maryland ... More >> Bioanalytical Systems, Inc. Baltimore, Maryland, United States, 21201 Less << |
NCT00864279 | Healthy | Phase 1 | Completed | - | United States, North Carolina ... More >> AAIPharma Inc.- AAI Clinic Morrisville, North Carolina, United States, 27560 Less << |
NCT00863902 | Healthy | Phase 1 | Completed | - | United States, North Carolina ... More >> AAIPharma Inc.- AAI Clinic Morrisville, North Carolina, United States, 27560 Less << |
NCT01781507 | Allergic Rhinitis ... More >> Asthma Less << | Phase 4 | Completed | - | United States, California ... More >> California Allergy and Asthma Medical Group Los Angeles, California, United States, 90025 Less << |
NCT02132169 | - | Completed | - | - | |
NCT03340740 | Allergic Rhinitis ... More >> Asthma Less << | Phase 4 | Recruiting | December 31, 2018 | United States, New York ... More >> Jacobi Medical Center Recruiting Bronx, New York, United States, 10461 Contact: Stephen Blumberg, MD 718-918-5826 stephen.blumberg@nychhc.org Contact: Katherine Huston, MD 718-918-5875 hustonk@nychhc.org Less << |
NCT02932774 | Allergic Rhinitis ... More >> Hay Fever SAR Rhinitis, Allergic, Seasonal Less << | Phase 4 | Completed | - | - |
NCT01064102 | Healthy | Phase 1 | Completed | - | - |
NCT02865018 | Neuromyelitis Optica | Phase 1 Phase 2 | Completed | - | United States, New York ... More >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Less << |
NCT01916226 | - | Completed | - | - | |
NCT01064115 | Healthy | Phase 1 | Completed | - | - |
NCT03772158 | Allergy | Phase 1 | Recruiting | February 3, 2019 | Canada, Quebec ... More >> Algorithme (An altascience Company) Recruiting Mount-Royal, Quebec, Canada, H3P 3P1 Contact: Bich-Chau Le +1 (514) 858-6077 ext ext. 3236 Bich-Chau@altasciences.com Principal Investigator: Eric Sicard, MD Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.57mL 0.51mL 0.26mL |
12.86mL 2.57mL 1.29mL |
25.71mL 5.14mL 2.57mL |